Essa Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

1 November 2024

Essa terminates an N-terminal journey

After beating "historical" Xtandi masofaniten fails to beat actual Xtandi.

Subscribe to Essa Pharmaceuticals